<DOC>
	<DOC>NCT01175811</DOC>
	<brief_summary>The purpose of the study is to compare the effects on overall glycaemic control of two insulin intensification therapies.</brief_summary>
	<brief_title>A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Present with type 2 diabetes mellitus Have been receiving twicedaily premixed insulin therapy with or without metformin and/or alphaglucosidase inhibitors, for at least six months prior to study entry Have Haemoglobin A1c (HbA1c) &gt;7.0% and &lt;12.0% Within the last 3 months prior to entry into the study, are taking any nonpermitted glucoselowering agents, or are taking any nonpermitted oral antihyperglycaemic medications Are pregnant or intend to become pregnant during the course of the study, or are sexually active women of childbearing potential not actively practicing birth control by a method determined by the investigator to be medically acceptable. Are women who are breastfeeding. Have an irregular sleep/wake cycle (for example, participants who sleep during the day and work during the night). Do not regularly consume three meals per day. Have a body mass index &gt;35 kilogram per square meter (kg/m^2). Have had more than one episode of severe hypoglycaemia within 24 weeks prior to entry into the study. Have cardiac disease with a functional status that is Class III or IV Have a history of renal or liver disease Have used less than or equal to 20 Units per day (U/day) of insulin during the past 90 days for more than 14 days (accumulated).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Diabetes Mellitus, Type 2</keyword>
	<keyword>Glargine</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Insulin LISPRO</keyword>
	<keyword>Insulin</keyword>
</DOC>